Gelonghui, Feb. 7 | Sihuan Pharmaceutical (00460.HK) announced that the Tonghua Intermediate People's Court of Jilin Province issued a decision to Jiyao Holding Group Co., Ltd. on November 27, 2023, deciding to initiate pre-restructuring procedures against Ji Yao Holdings and appoint a temporary manager to carry out related work during the pre-restructuring period. Subsequently, Jiyao Holdings issued an announcement to publicly recruit investors for the restructuring. Longyu Hongda Investment Management Co., Ltd., a subsidiary of the company, formed a consortium with other industrial and financial investors to sign up to participate in the bankruptcy and restructuring project of Ji Pharmaceutical Holdings. The consortium was recently notified by the temporary manager of Ji Pharmaceutical Holdings that the consortium with Longyu Hongda as the lead was assessed by the Ji Pharmaceutical Holdings Pre-Reorganization Investor Selection and Review Committee according to law and selected as the pre-restructuring investor for the bankruptcy and restructuring project of Ji Pharmaceutical Holdings.
四环医药(00460.HK)：参与联合体中选吉药控股破产重整项目预重整投资人
Sihuan Pharmaceutical (00460.HK): Participating in the pre-restructuring investors selected for the bankruptcy and restructuring project of Ji Pharmaceutical Holdings
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more